What are SBIR and STTR Programs?
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, also known as America’s Seed Fund, are one of the largest sources of early-stage capital for technology commercialization in the United States. These programs allow US-owned and operated small businesses to engage in federal research and development that has a strong potential for commercialization.
In Fiscal Year 2016, NIH’s SBIR and STTR programs will invest over 870 million dollars into health and life science companies that are creating innovative technologies that align with NIH’s mission to improve health and save lives. A key objective of this work is translating promising technologies to the private sector through strategic public and private partnerships, enabling life-saving innovations to reach consumer markets.
The NIH SBIR program funds early stage small businesses that are seeking to commercialize innovative biomedical technologies. This competitive program helps small businesses participate in federal research and development, develop life-saving technologies, and create jobs.